Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...
Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.
Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...
Opinion
Viewpoints: Ultra-Processed Foods Require Better FDA Research; How Will RFK Jr. Perform In New Job?Editorial writers dissect these public health topics.
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Welcome to the Biofrontera Inc. Third Quarter 2024 Financial ...
WASHINGTON/NEW YORK (Reuters) - Robert F. Kennedy Jr. vowed to purge the U.S. Food and Drug Administration shortly before ...
The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback